IMF-001 Phase 1 Study With Refractory Esophageal Tumor.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2013
At a glance
- Drugs IMF 001 (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 04 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Jan 2012 Planned end date changed from 1 Mar 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.